Stem Sinks as Goldman Downgrades on Recent Weak Guidance, Execution
Stem Analyst Ratings
Susquehanna Trims Price Target on Stem to $4 From $5.50, Maintains Positive Rating
Goldman Sachs Maintains Buy on Stem, Lowers Price Target to $6
Stem Analyst Ratings
Stem Analyst Ratings
Analysts Offer Insights on Technology Companies: Stem Inc (STEM), Codexis (CDXS) and CGI Group (GIB)
Stem Analyst Ratings
Promising Outlook for Stem Inc: A Comprehensive Analysis Supporting a Buy Rating
Roth MKM Maintains Neutral on Stem, Lowers Price Target to $3.7
Stem Analyst Ratings
Analysts Offer Insights on Technology Companies: Monolithic Power (MPWR), Stem Inc (STEM) and Pacific Biosciences (PACB)
Barclays Maintains Equal-Weight on Stem, Lowers Price Target to $5
Stem Analyst Ratings
Exane BNP Paribas Initiates Coverage On Stem With Neutral Rating, Announces Price Target of $5
Stem Analyst Ratings
Stem Analyst Ratings
Goldman Sachs Adjusts Price Target on Stem to $7 From $9.50, Maintains Buy Rating
Piper Sandler Maintains Neutral on Stem, Lowers Price Target to $4
Stem Analyst Ratings
No Data